ÂÜÀòÂÒÂ×

Camilla Myhre Sandberg is a seasoned executive with extensive experience in biotechnology and healthcare sectors. Currently serving as the CEO of Miris Holding AB and Miris AB, as well as a board member at Monivent AB and NextCell Pharma AB, Camilla has a strong track record in strategic leadership and commercial development. Prior roles include Vice President of Global Sales & Marketing at BioLamina AB, where efforts led to significant sales growth, and various strategic marketing leadership positions at GE Healthcare Life Sciences, focusing on cell technologies and business development. Camilla holds an M.Sc. in Toxicology from the University of Oslo and has furthered their education at BI Norwegian Business School and Mid Sweden University.